| Literature DB >> 30877580 |
José A Bauermeister1, Jesse M Golinkoff2, Alex Carballo-Diéguez3,4, Rebecca Giguere3, Daniela López5, Craig J Hoesley6, Beatrice A Chen7,8, Peter Anderson9, Charlene S Dezzutti7,8, Julie Strizki10, Carol Sprinkle11, Faye Heard6, Wayne Hall8, Cindy Jacobson8, Jennifer Berthiaume12, Ashley Mayo13, Barbra A Richardson12, Jeanna Piper14.
Abstract
Intravaginal rings (IVR) containing antiretroviral drugs are a promising method for HIV prevention. We triangulated quantitative and qualitative assessments to evaluate the acceptability of four IVRs used continuously for 28 days as part of a Phase I trial (N = 48 HIV-negative women; ages 18-45). Adherence was high throughout the trial, yet 30% of participants reported involuntary IVR expulsions followed by re-insertion. Most participants (93.6%) felt comfortable with the IVR being inside their body. Participants reported liking the IVR more (36.2%) or the same amount (55.3%) since starting the study. When given the option of choosing between the IVR and/or a male condom for HIV-prevention, most reported preferring the IVR (n = 29, 63.0%), and over a quarter of the sample reported liking them equally (n = 12, 26.1%). We observed no differences in IVR acceptability across the study arms. High adherence and acceptability underscores the promise of an IVR as a female-controlled, sustained mechanism for HIV prevention.Entities:
Keywords: HIV prevention; Microbicide; Vaginal ring; Women
Mesh:
Substances:
Year: 2020 PMID: 30877580 PMCID: PMC6745293 DOI: 10.1007/s10461-019-02457-0
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165